Sign In
Buy ITT
$199.23
+2.42 (+1.23%)
At Close: Jun 22, 2026
ITT Reports First-Quarter 2020 Results
10:45am, Friday, 01'st May 2020
ITT Inc. (NYSE: ITT) today reported 2020 first-quarter financial results that reflect our resilience in this challenging global economic environment.
ITT Q1 2020 Earnings Preview
09:30pm, Thursday, 30'th Apr 2020
ITT (NYSE:ITT) is scheduled to announce Q1 earnings results on Friday, May 1st, before market open.The consensus EPS Estimate is $0.75 (-17.6% Y/Y) and the consensus Revenue Estimate is $631.89M (-9.1
The Lancet Oncology Publishes Details of UroGen Pharma’s Pivotal OLYMPUS Trial
12:00pm, Thursday, 30'th Apr 2020
UroGen Pharma Ltd. (Nasdaq: URGN) today announced The Lancet Oncology published results from the pivotal Phase 3 OLYMPUS trial, reporting that 59% of low-grade upper tract urothelial cancer (LG-UTUC)
Talicia® is the first and only FDA-approved rifabutin-based therapy for H. pylori infection, designed as a first-line option to address the high resistance of H. pylori bacteria.
Global Water Treatment Chemicals and Technology Market 2020 Growth Factors, Types and Application by Regional Geography 2024
07:40am, Tuesday, 28'th Apr 2020
Apr 28, 2020 (The Expresswire) --
The report outlines the competitive framework of the “Water Treatment Chemicals and Technology Market” industry detailing...
ITT Inc. Updates Call Time for Q1 2020 Investor Briefing on May 1
03:00pm, Monday, 27'th Apr 2020
As previously announced, ITT Inc. (NYSE: ITT) will release its first-quarter 2020 financial results on the investor relations section of its website at 6:45 a.m. Eastern Time, on Friday, May 1, 2020.
